Filing Details
- Accession Number:
- 0001104659-18-047460
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-26 17:26:02
- Reporting Period:
- 2018-07-24
- Accepted Time:
- 2018-07-26 17:26:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737953 | Replimune Group Inc. | REPL | Biological Products, (No Disgnostic Substances) (2836) | 822082553 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744922 | Alexander Hugo Slootweg | 18 Commerce Way Woburn MA 01801 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-24 | 994,688 | $0.00 | 994,688 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2018-07-24 | 2,579,881 | $0.00 | 3,574,569 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2018-07-24 | 1,013,547 | $0.00 | 4,588,116 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2018-07-24 | 133,333 | $15.00 | 4,721,449 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to buy) | Acquisiton | 2018-07-24 | 248,672 | $0.00 | 248,672 | $0.00 |
Series Seed Convertible Preferred Stock | Warrant (right to buy) | Disposition | 2018-07-24 | 248,672 | $0.00 | 248,672 | $0.00 |
Common Stock | Series Seed Convertible Preferred Stock | Disposition | 2018-07-24 | 994,688 | $0.00 | 994,688 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-07-24 | 2,579,881 | $0.00 | 2,579,881 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2018-07-24 | 1,013,547 | $0.00 | 1,013,547 | $0.00 |
Common Stock | Stock Option (right to buy) | Acquisiton | 2018-07-24 | 13,500 | $0.00 | 13,500 | $15.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
248,672 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
13,500 | 2028-07-19 | No | 4 | A | Direct |
Footnotes
- In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the "Preferred Stock") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date.
- The securities are held directly by Forbion Capital Fund III Cooperatief U.A ("Forbion Coop"). Forbion III Management B.V. ("Forbion Management") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any.
- Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock.
- Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis.
- This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 24 equal monthly installments thereafter.